← back to search

Nikolai V. Ivanov

Philip Morris International (Switzerland) · CH
Area of research
Health, Toxicology and Mutagenesis · Molecular Biology
Research interest
Research interests include Air Quality and Health Impacts, Plant tissue culture and regeneration, Smoking Behavior and Cessation, and Carcinogens and Genotoxicity Assessment.
h-index
41
citations
5,266
works
226
NIH funding
primary concept
email

Recent publications

Author Correction: The clove (Syzygium aromaticum) genome provides insights into the eugenol biosynthesis pathway.
2025cited by 0position: contributordoi
Identification of Granatane Alkaloids from <i>Duboisia myoporoides</i> (Solanaceae) using Molecular Networking and Semisynthesis.
2024cited by 1position: contributordoi
Quantification and Mapping of Alkylation in the Human Genome Reveal Single Nucleotide Resolution Precursors of Mutational Signatures.
2023cited by 16position: contributordoi
Dissection of Cancer Mutational Signatures with Individual Components of Cigarette Smoking.
2023cited by 11position: contributordoi
Acclimation strategies of the green alga Chlorella vulgaris to different light regimes revealed by physiological and comparative proteomic analyses.
2023cited by 4position: contributordoi
<i>Nicotiana noctiflora</i> Hook. Genome Contains Two Cellular T-DNAs with Functional Genes.
2023cited by 0position: contributordoi
The clove (Syzygium aromaticum) genome provides insights into the eugenol biosynthesis pathway.
2022cited by 18position: contributordoi
Natural and induced variations in transcriptional regulator genes result in low-nicotine phenotypes in tobacco.
2022cited by 13position: contributordoi
PYL1- and PYL8-like ABA Receptors of <i>Nicotiana benthamiana</i> Play a Key Role in ABA Response in Seed and Vegetative Tissue.
2022cited by 7position: contributordoi
Application of Secondary Electrospray Ionization Coupled with High-Resolution Mass Spectrometry in Chemical Characterization of Thermally Generated Aerosols.
2022cited by 6position: contributordoi
Fractionation and Extraction Optimization of Potentially Valuable Compounds and Their Profiling in Six Varieties of Two <i>Nicotiana</i> Species.
2022cited by 2position: contributordoi
A 7-month inhalation toxicology study in C57BL/6 mice demonstrates reduced pulmonary inflammation and emphysematous changes following smoking cessation or switching to e-vapor products
Toxicology Research and Application 2021cited by 4position: contributordoi
Metabolic networks of the Nicotiana genus in the spotlight: content, progress and outlook.
2021cited by 1position: contributordoi
Phage T7 DNA mimic protein Ocr is a potent inhibitor of BREX defence
Nucleic Acids Research 2020cited by 99position: contributordoi
The reduction of DSS-induced colitis severity in mice exposed to cigarette smoke is linked to immune modulation and microbial shifts.
2020cited by 26position: contributordoi
Comparing the preclinical risk profile of inhalable candidate and potential candidate modified risk tobacco products: A bridging use case
Toxicology Reports 2020cited by 9position: contributordoi
Application of a multi-layer systems toxicology framework for in vitro assessment of the biological effects of Classic Tobacco e-liquid and its corresponding aerosol using an e-cigarette device with MESH™ technology.
2019cited by 21position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 17 papers (2019–2025)Manuel Peitsch · Philip Morris International (Switzerland)4 papers (2019–2025)Bjoern Titz · Roche (Switzerland)3 papers (2019–2023)Julia Hoeng · Novartis (Switzerland)2 papers (2019–2021)Felix Kessler · Elsevier, Inc.2 papers (2022–2025)Shana J. Sturla · ETH Zurich2 papers (2023–2023)Anita R. Iskandar · University of Miskolc2 papers (2019–2020)Simon Goepfert · Philip Morris International (Switzerland)2 papers (2022–2025)Cécile Mingard · ETH Zurich2 papers (2023–2023)Vakil Takhaveev · ETH Zurich2 papers (2023–2023)Sonia Ouadi · Philip Morris International (Switzerland)2 papers (2022–2025)Kacper P. Kaminski · 2 papers (2022–2022) · 2 papers (2019–2020)Ashutosh Kumar · Altria Client Services Inc1 papers (2021–2021)Kazuki Saito · Toyama Institute of Health1 papers (2022–2022)Jorge Lozano-Juste · Instituto de Biología Molecular y Celular de Plantas1 papers (2022–2022)Marta Vazquez-Vilar · Instituto de Biología Molecular y Celular de Plantas1 papers (2022–2022)Athanasios Kondylis · Philip Morris International (Switzerland)1 papers (2019–2019)Matteo Ballottari · American Chemical Society1 papers (2023–2023)Tatiana V. Matveeva · All-Russian Institute of Plant Protection1 papers (2023–2023)